Global Conjugate Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Conjugate Vaccine market size is predicted to grow from US$ 10410 million in 2025 to US$ 12660 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
LP Information, Inc. (LPI) ' newest research report, the “Conjugate Vaccine Industry Forecast” looks at past sales and reviews total world Conjugate Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Conjugate Vaccine sales for 2025 through 2031. With Conjugate Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Conjugate Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Conjugate Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Conjugate Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Conjugate Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Conjugate Vaccine and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Conjugate Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Conjugate Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Conjugate Vaccine market?
What factors are driving Conjugate Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Conjugate Vaccine market opportunities vary by end market size?
How does Conjugate Vaccine break out by Type, by End Users?
The global Conjugate Vaccine market size is predicted to grow from US$ 10410 million in 2025 to US$ 12660 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
LP Information, Inc. (LPI) ' newest research report, the “Conjugate Vaccine Industry Forecast” looks at past sales and reviews total world Conjugate Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Conjugate Vaccine sales for 2025 through 2031. With Conjugate Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Conjugate Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Conjugate Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Conjugate Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Conjugate Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Conjugate Vaccine and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Conjugate Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Conjugate Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Hib Vaccine
- Meningococcal Vaccine
- Pneumococcal Vaccine
- Others
- Children
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- Sanofi
- Merck
- Walvax Biotechnology
- Royal (Wuxi) Bio-Pharmaceutical
- Bharat Biotech
- Zhifei Biologic
What is the 10-year outlook for the global Conjugate Vaccine market?
What factors are driving Conjugate Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Conjugate Vaccine market opportunities vary by end market size?
How does Conjugate Vaccine break out by Type, by End Users?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Conjugate Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Conjugate Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Conjugate Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Conjugate Vaccine Segment by Type
2.2.1 Hib Vaccine
2.2.2 Meningococcal Vaccine
2.2.3 Pneumococcal Vaccine
2.2.4 Others
2.3 Conjugate Vaccine Sales by Type
2.3.1 Global Conjugate Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Conjugate Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Conjugate Vaccine Sale Price by Type (2020-2025)
2.4 Conjugate Vaccine Segment by End Users
2.4.1 Children
2.4.2 Adult
2.5 Conjugate Vaccine Sales by End Users
2.5.1 Global Conjugate Vaccine Sale Market Share by End Users (2020-2025)
2.5.2 Global Conjugate Vaccine Revenue and Market Share by End Users (2020-2025)
2.5.3 Global Conjugate Vaccine Sale Price by End Users (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Conjugate Vaccine Breakdown Data by Company
3.1.1 Global Conjugate Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Conjugate Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Conjugate Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Conjugate Vaccine Revenue by Company (2020-2025)
3.2.2 Global Conjugate Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Conjugate Vaccine Sale Price by Company
3.4 Key Manufacturers Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Conjugate Vaccine Product Location Distribution
3.4.2 Players Conjugate Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONJUGATE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Conjugate Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Conjugate Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Conjugate Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Conjugate Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Conjugate Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Conjugate Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Conjugate Vaccine Sales Growth
4.4 APAC Conjugate Vaccine Sales Growth
4.5 Europe Conjugate Vaccine Sales Growth
4.6 Middle East & Africa Conjugate Vaccine Sales Growth
5 AMERICAS
5.1 Americas Conjugate Vaccine Sales by Country
5.1.1 Americas Conjugate Vaccine Sales by Country (2020-2025)
5.1.2 Americas Conjugate Vaccine Revenue by Country (2020-2025)
5.2 Americas Conjugate Vaccine Sales by Type (2020-2025)
5.3 Americas Conjugate Vaccine Sales by End Users (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Conjugate Vaccine Sales by Region
6.1.1 APAC Conjugate Vaccine Sales by Region (2020-2025)
6.1.2 APAC Conjugate Vaccine Revenue by Region (2020-2025)
6.2 APAC Conjugate Vaccine Sales by Type (2020-2025)
6.3 APAC Conjugate Vaccine Sales by End Users (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Conjugate Vaccine by Country
7.1.1 Europe Conjugate Vaccine Sales by Country (2020-2025)
7.1.2 Europe Conjugate Vaccine Revenue by Country (2020-2025)
7.2 Europe Conjugate Vaccine Sales by Type (2020-2025)
7.3 Europe Conjugate Vaccine Sales by End Users (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Conjugate Vaccine by Country
8.1.1 Middle East & Africa Conjugate Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Conjugate Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Conjugate Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Conjugate Vaccine Sales by End Users (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Conjugate Vaccine
10.3 Manufacturing Process Analysis of Conjugate Vaccine
10.4 Industry Chain Structure of Conjugate Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Conjugate Vaccine Distributors
11.3 Conjugate Vaccine Customer
12 WORLD FORECAST REVIEW FOR CONJUGATE VACCINE BY GEOGRAPHIC REGION
12.1 Global Conjugate Vaccine Market Size Forecast by Region
12.1.1 Global Conjugate Vaccine Forecast by Region (2026-2031)
12.1.2 Global Conjugate Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Conjugate Vaccine Forecast by Type (2026-2031)
12.7 Global Conjugate Vaccine Forecast by End Users (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Conjugate Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Conjugate Vaccine Product Portfolios and Specifications
13.2.3 GSK Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Conjugate Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Conjugate Vaccine Product Portfolios and Specifications
13.4.3 Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Conjugate Vaccine Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Royal (Wuxi) Bio-Pharmaceutical
13.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
13.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolios and Specifications
13.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview
13.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments
13.7 Bharat Biotech
13.7.1 Bharat Biotech Company Information
13.7.2 Bharat Biotech Conjugate Vaccine Product Portfolios and Specifications
13.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bharat Biotech Main Business Overview
13.7.5 Bharat Biotech Latest Developments
13.8 Zhifei Biologic
13.8.1 Zhifei Biologic Company Information
13.8.2 Zhifei Biologic Conjugate Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhifei Biologic Main Business Overview
13.8.5 Zhifei Biologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Conjugate Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Conjugate Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hib Vaccine
Table 4. Major Players of Meningococcal Vaccine
Table 5. Major Players of Pneumococcal Vaccine
Table 6. Major Players of Others
Table 7. Global Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 8. Global Conjugate Vaccine Sales Market Share byType (2020-2025)
Table 9. Global Conjugate Vaccine Revenue byType (2020-2025) & ($ million)
Table 10. Global Conjugate Vaccine Revenue Market Share byType (2020-2025)
Table 11. Global Conjugate Vaccine Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Conjugate Vaccine Sale by End Users (2020-2025) & (Million Unit)
Table 13. Global Conjugate Vaccine Sale Market Share by End Users (2020-2025)
Table 14. Global Conjugate Vaccine Revenue by End Users (2020-2025) & ($ million)
Table 15. Global Conjugate Vaccine Revenue Market Share by End Users (2020-2025)
Table 16. Global Conjugate Vaccine Sale Price by End Users (2020-2025) & (USD/Unit)
Table 17. Global Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 18. Global Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Conjugate Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Conjugate Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Conjugate Vaccine Producing Area Distribution and Sales Area
Table 23. Players Conjugate Vaccine Products Offered
Table 24. Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Conjugate Vaccine Sales by Geographic Region (2020-2025) & (Million Unit)
Table 28. Global Conjugate Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Conjugate Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Conjugate Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Conjugate Vaccine Sales by Country/Region (2020-2025) & (Million Unit)
Table 32. Global Conjugate Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Conjugate Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Conjugate Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 36. Americas Conjugate Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Conjugate Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 39. Americas Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 40. APAC Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 41. APAC Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Conjugate Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 44. APAC Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 45. Europe Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 46. Europe Conjugate Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 48. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 49. Middle East & Africa Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 50. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 52. Middle East & Africa Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 53. Key Market Drivers & Growth Opportunities of Conjugate Vaccine
Table 54. Key Market Challenges & Risks of Conjugate Vaccine
Table 55. Key IndustryTrends of Conjugate Vaccine
Table 56. Conjugate Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Conjugate Vaccine Distributors List
Table 59. Conjugate Vaccine Customer List
Table 60. Global Conjugate Vaccine SalesForecast by Region (2026-2031) & (Million Unit)
Table 61. Global Conjugate Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 63. Americas Conjugate Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Conjugate Vaccine SalesForecast by Region (2026-2031) & (Million Unit)
Table 65. APAC Conjugate Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 67. Europe Conjugate Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 69. Middle East & Africa Conjugate Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Conjugate Vaccine SalesForecast byType (2026-2031) & (Million Unit)
Table 71. Global Conjugate Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Conjugate Vaccine SalesForecast by End Users (2026-2031) & (Million Unit)
Table 73. Global Conjugate Vaccine RevenueForecast by End Users (2026-2031) & ($ millions)
Table 74. Pfizer Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Conjugate Vaccine Product Portfolios and Specifications
Table 76. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. GSK Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Conjugate Vaccine Product Portfolios and Specifications
Table 81. GSK Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Sanofi Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Conjugate Vaccine Product Portfolios and Specifications
Table 86. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Merck Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Conjugate Vaccine Product Portfolios and Specifications
Table 91. Merck Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Merck Main Business
Table 93. Merck Latest Developments
Table 94. Walvax Biotechnology Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Walvax Biotechnology Conjugate Vaccine Product Portfolios and Specifications
Table 96. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Walvax Biotechnology Main Business
Table 98. Walvax Biotechnology Latest Developments
Table 99. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolios and Specifications
Table 101. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Royal (Wuxi) Bio-Pharmaceutical Main Business
Table 103. Royal (Wuxi) Bio-Pharmaceutical Latest Developments
Table 104. Bharat Biotech Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Bharat Biotech Conjugate Vaccine Product Portfolios and Specifications
Table 106. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Bharat Biotech Main Business
Table 108. Bharat Biotech Latest Developments
Table 109. Zhifei Biologic Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Zhifei Biologic Conjugate Vaccine Product Portfolios and Specifications
Table 111. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zhifei Biologic Main Business
Table 113. Zhifei Biologic Latest Developments
LIST OFFIGURES
Figure 1. Picture of Conjugate Vaccine
Figure 2. Conjugate Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Conjugate Vaccine Sales Growth Rate 2020-2031 (Million Unit)
Figure 7. Global Conjugate Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Conjugate Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Conjugate Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Conjugate Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Hib Vaccine
Figure 12. Product Picture of Meningococcal Vaccine
Figure 13. Product Picture of Pneumococcal Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Conjugate Vaccine Sales Market Share byType in 2025
Figure 16. Global Conjugate Vaccine Revenue Market Share byType (2020-2025)
Figure 17. Conjugate Vaccine Consumed in Children
Figure 18. Global Conjugate Vaccine Market: Children (2020-2025) & (Million Unit)
Figure 19. Conjugate Vaccine Consumed in Adult
Figure 20. Global Conjugate Vaccine Market: Adult (2020-2025) & (Million Unit)
Figure 21. Global Conjugate Vaccine Sale Market Share by End Users (2024)
Figure 22. Global Conjugate Vaccine Revenue Market Share by End Users in 2025
Figure 23. Conjugate Vaccine Sales by Company in 2025 (Million Unit)
Figure 24. Global Conjugate Vaccine Sales Market Share by Company in 2025
Figure 25. Conjugate Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Conjugate Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Conjugate Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Conjugate Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 30. Americas Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 32. APAC Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 34. Europe Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 36. Middle East & Africa Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Conjugate Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 40. Americas Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 41. United States Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Conjugate Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Conjugate Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 48. APAC Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 49. China Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Conjugate Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 59. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 60. Germany Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61.France Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 68. Egypt Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Conjugate Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Conjugate Vaccine
Figure 75. Industry Chain Structure of Conjugate Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Conjugate Vaccine Sales MarketForecast by Region (2026-2031)
Figure 78. Global Conjugate Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Conjugate Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Conjugate Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Conjugate Vaccine Sales Market ShareForecast by End Users (2026-2031)
Figure 82. Global Conjugate Vaccine Revenue Market ShareForecast by End Users (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Conjugate Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Conjugate Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Conjugate Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Conjugate Vaccine Segment by Type
2.2.1 Hib Vaccine
2.2.2 Meningococcal Vaccine
2.2.3 Pneumococcal Vaccine
2.2.4 Others
2.3 Conjugate Vaccine Sales by Type
2.3.1 Global Conjugate Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Conjugate Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Conjugate Vaccine Sale Price by Type (2020-2025)
2.4 Conjugate Vaccine Segment by End Users
2.4.1 Children
2.4.2 Adult
2.5 Conjugate Vaccine Sales by End Users
2.5.1 Global Conjugate Vaccine Sale Market Share by End Users (2020-2025)
2.5.2 Global Conjugate Vaccine Revenue and Market Share by End Users (2020-2025)
2.5.3 Global Conjugate Vaccine Sale Price by End Users (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Conjugate Vaccine Breakdown Data by Company
3.1.1 Global Conjugate Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Conjugate Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Conjugate Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Conjugate Vaccine Revenue by Company (2020-2025)
3.2.2 Global Conjugate Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Conjugate Vaccine Sale Price by Company
3.4 Key Manufacturers Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Conjugate Vaccine Product Location Distribution
3.4.2 Players Conjugate Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONJUGATE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Conjugate Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Conjugate Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Conjugate Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Conjugate Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Conjugate Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Conjugate Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Conjugate Vaccine Sales Growth
4.4 APAC Conjugate Vaccine Sales Growth
4.5 Europe Conjugate Vaccine Sales Growth
4.6 Middle East & Africa Conjugate Vaccine Sales Growth
5 AMERICAS
5.1 Americas Conjugate Vaccine Sales by Country
5.1.1 Americas Conjugate Vaccine Sales by Country (2020-2025)
5.1.2 Americas Conjugate Vaccine Revenue by Country (2020-2025)
5.2 Americas Conjugate Vaccine Sales by Type (2020-2025)
5.3 Americas Conjugate Vaccine Sales by End Users (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Conjugate Vaccine Sales by Region
6.1.1 APAC Conjugate Vaccine Sales by Region (2020-2025)
6.1.2 APAC Conjugate Vaccine Revenue by Region (2020-2025)
6.2 APAC Conjugate Vaccine Sales by Type (2020-2025)
6.3 APAC Conjugate Vaccine Sales by End Users (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Conjugate Vaccine by Country
7.1.1 Europe Conjugate Vaccine Sales by Country (2020-2025)
7.1.2 Europe Conjugate Vaccine Revenue by Country (2020-2025)
7.2 Europe Conjugate Vaccine Sales by Type (2020-2025)
7.3 Europe Conjugate Vaccine Sales by End Users (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Conjugate Vaccine by Country
8.1.1 Middle East & Africa Conjugate Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Conjugate Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Conjugate Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Conjugate Vaccine Sales by End Users (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Conjugate Vaccine
10.3 Manufacturing Process Analysis of Conjugate Vaccine
10.4 Industry Chain Structure of Conjugate Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Conjugate Vaccine Distributors
11.3 Conjugate Vaccine Customer
12 WORLD FORECAST REVIEW FOR CONJUGATE VACCINE BY GEOGRAPHIC REGION
12.1 Global Conjugate Vaccine Market Size Forecast by Region
12.1.1 Global Conjugate Vaccine Forecast by Region (2026-2031)
12.1.2 Global Conjugate Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Conjugate Vaccine Forecast by Type (2026-2031)
12.7 Global Conjugate Vaccine Forecast by End Users (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Conjugate Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Conjugate Vaccine Product Portfolios and Specifications
13.2.3 GSK Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Conjugate Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Conjugate Vaccine Product Portfolios and Specifications
13.4.3 Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Conjugate Vaccine Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Royal (Wuxi) Bio-Pharmaceutical
13.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
13.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolios and Specifications
13.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview
13.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments
13.7 Bharat Biotech
13.7.1 Bharat Biotech Company Information
13.7.2 Bharat Biotech Conjugate Vaccine Product Portfolios and Specifications
13.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bharat Biotech Main Business Overview
13.7.5 Bharat Biotech Latest Developments
13.8 Zhifei Biologic
13.8.1 Zhifei Biologic Company Information
13.8.2 Zhifei Biologic Conjugate Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhifei Biologic Main Business Overview
13.8.5 Zhifei Biologic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Conjugate Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Conjugate Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hib Vaccine
Table 4. Major Players of Meningococcal Vaccine
Table 5. Major Players of Pneumococcal Vaccine
Table 6. Major Players of Others
Table 7. Global Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 8. Global Conjugate Vaccine Sales Market Share byType (2020-2025)
Table 9. Global Conjugate Vaccine Revenue byType (2020-2025) & ($ million)
Table 10. Global Conjugate Vaccine Revenue Market Share byType (2020-2025)
Table 11. Global Conjugate Vaccine Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Conjugate Vaccine Sale by End Users (2020-2025) & (Million Unit)
Table 13. Global Conjugate Vaccine Sale Market Share by End Users (2020-2025)
Table 14. Global Conjugate Vaccine Revenue by End Users (2020-2025) & ($ million)
Table 15. Global Conjugate Vaccine Revenue Market Share by End Users (2020-2025)
Table 16. Global Conjugate Vaccine Sale Price by End Users (2020-2025) & (USD/Unit)
Table 17. Global Conjugate Vaccine Sales by Company (2020-2025) & (Million Unit)
Table 18. Global Conjugate Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Conjugate Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Conjugate Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Conjugate Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Conjugate Vaccine Producing Area Distribution and Sales Area
Table 23. Players Conjugate Vaccine Products Offered
Table 24. Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Conjugate Vaccine Sales by Geographic Region (2020-2025) & (Million Unit)
Table 28. Global Conjugate Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Conjugate Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Conjugate Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Conjugate Vaccine Sales by Country/Region (2020-2025) & (Million Unit)
Table 32. Global Conjugate Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Conjugate Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Conjugate Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 36. Americas Conjugate Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Conjugate Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 39. Americas Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 40. APAC Conjugate Vaccine Sales by Region (2020-2025) & (Million Unit)
Table 41. APAC Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Conjugate Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 44. APAC Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 45. Europe Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 46. Europe Conjugate Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 48. Europe Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 49. Middle East & Africa Conjugate Vaccine Sales by Country (2020-2025) & (Million Unit)
Table 50. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Conjugate Vaccine Sales byType (2020-2025) & (Million Unit)
Table 52. Middle East & Africa Conjugate Vaccine Sales by End Users (2020-2025) & (Million Unit)
Table 53. Key Market Drivers & Growth Opportunities of Conjugate Vaccine
Table 54. Key Market Challenges & Risks of Conjugate Vaccine
Table 55. Key IndustryTrends of Conjugate Vaccine
Table 56. Conjugate Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Conjugate Vaccine Distributors List
Table 59. Conjugate Vaccine Customer List
Table 60. Global Conjugate Vaccine SalesForecast by Region (2026-2031) & (Million Unit)
Table 61. Global Conjugate Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 63. Americas Conjugate Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Conjugate Vaccine SalesForecast by Region (2026-2031) & (Million Unit)
Table 65. APAC Conjugate Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 67. Europe Conjugate Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Conjugate Vaccine SalesForecast by Country (2026-2031) & (Million Unit)
Table 69. Middle East & Africa Conjugate Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Conjugate Vaccine SalesForecast byType (2026-2031) & (Million Unit)
Table 71. Global Conjugate Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Conjugate Vaccine SalesForecast by End Users (2026-2031) & (Million Unit)
Table 73. Global Conjugate Vaccine RevenueForecast by End Users (2026-2031) & ($ millions)
Table 74. Pfizer Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Conjugate Vaccine Product Portfolios and Specifications
Table 76. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. GSK Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Conjugate Vaccine Product Portfolios and Specifications
Table 81. GSK Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Sanofi Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Conjugate Vaccine Product Portfolios and Specifications
Table 86. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Merck Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Conjugate Vaccine Product Portfolios and Specifications
Table 91. Merck Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Merck Main Business
Table 93. Merck Latest Developments
Table 94. Walvax Biotechnology Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Walvax Biotechnology Conjugate Vaccine Product Portfolios and Specifications
Table 96. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Walvax Biotechnology Main Business
Table 98. Walvax Biotechnology Latest Developments
Table 99. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolios and Specifications
Table 101. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Royal (Wuxi) Bio-Pharmaceutical Main Business
Table 103. Royal (Wuxi) Bio-Pharmaceutical Latest Developments
Table 104. Bharat Biotech Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Bharat Biotech Conjugate Vaccine Product Portfolios and Specifications
Table 106. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Bharat Biotech Main Business
Table 108. Bharat Biotech Latest Developments
Table 109. Zhifei Biologic Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Zhifei Biologic Conjugate Vaccine Product Portfolios and Specifications
Table 111. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zhifei Biologic Main Business
Table 113. Zhifei Biologic Latest Developments
LIST OFFIGURES
Figure 1. Picture of Conjugate Vaccine
Figure 2. Conjugate Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Conjugate Vaccine Sales Growth Rate 2020-2031 (Million Unit)
Figure 7. Global Conjugate Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Conjugate Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Conjugate Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Conjugate Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Hib Vaccine
Figure 12. Product Picture of Meningococcal Vaccine
Figure 13. Product Picture of Pneumococcal Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Conjugate Vaccine Sales Market Share byType in 2025
Figure 16. Global Conjugate Vaccine Revenue Market Share byType (2020-2025)
Figure 17. Conjugate Vaccine Consumed in Children
Figure 18. Global Conjugate Vaccine Market: Children (2020-2025) & (Million Unit)
Figure 19. Conjugate Vaccine Consumed in Adult
Figure 20. Global Conjugate Vaccine Market: Adult (2020-2025) & (Million Unit)
Figure 21. Global Conjugate Vaccine Sale Market Share by End Users (2024)
Figure 22. Global Conjugate Vaccine Revenue Market Share by End Users in 2025
Figure 23. Conjugate Vaccine Sales by Company in 2025 (Million Unit)
Figure 24. Global Conjugate Vaccine Sales Market Share by Company in 2025
Figure 25. Conjugate Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Conjugate Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Conjugate Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Conjugate Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 30. Americas Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 32. APAC Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 34. Europe Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Conjugate Vaccine Sales 2020-2025 (Million Unit)
Figure 36. Middle East & Africa Conjugate Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Conjugate Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 40. Americas Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 41. United States Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Conjugate Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Conjugate Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 48. APAC Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 49. China Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Conjugate Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Conjugate Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 59. Europe Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 60. Germany Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61.France Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Conjugate Vaccine Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Conjugate Vaccine Sales Market Share by End Users (2020-2025)
Figure 68. Egypt Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Conjugate Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Conjugate Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Conjugate Vaccine
Figure 75. Industry Chain Structure of Conjugate Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Conjugate Vaccine Sales MarketForecast by Region (2026-2031)
Figure 78. Global Conjugate Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Conjugate Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Conjugate Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Conjugate Vaccine Sales Market ShareForecast by End Users (2026-2031)
Figure 82. Global Conjugate Vaccine Revenue Market ShareForecast by End Users (2026-2031)
More Publications
Global Invisible Braces Market Growth 2025-2031
US$ 3,660.00
March 2025
145 pages
Global Spinal Surgical Robots Market Growth 2025-2031
US$ 3,660.00
March 2025
97 pages
Global Gutta Percha Obturator Market Growth 2024-2030
US$ 3,660.00
March 2024
112 pages
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
95 pages
